CG
FLGT icon

Cutler Group’s Fulgent Genetics FLGT Stock Holding History

Cutler Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,100
Closed -$38K – 5088
2022
Q2 		$38K Sell
6,100
-3,100
-34% -$170K ﹤0.01% 2152
2022
Q1 		$37K Buy
9,200
+1,800
+24% +$119K ﹤0.01% 2502
2021
Q4 		$26K Buy
7,400
+2,400
+48% +$211K ﹤0.01% 2914
2021
Q3 		$45K Sell
5,000
-12,200
-71% -$1.11M ﹤0.01% 2599
2021
Q2 		$250K Sell
17,200
-12,100
-41% -$966K 0.01% 1180
2021
Q1 		$565K Buy
29,300
+19,200
+190% +$1.98M 0.03% 672
2020
Q4 		$56K Buy
10,100
+8,400
+494% +$351K ﹤0.01% 1927
2020
Q3 		$7K Buy
+1,700
New +$53.2K ﹤0.01% 3242

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cutler Group's FLGT Position: Q4 2023 in Review

Cutler Group sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 106 shares — an estimated $2K sold.

Cutler Group first reported a position in FLGT in Q3 2020 and held it in 10 quarters. The position peaked at $669K in Q1 2021. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • Cutler Group reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 106 Fulgent Genetics shares in Q4 2023, an estimated $2K.
  • Cutler Group first reported a position in Fulgent Genetics in Q3 2020 and held it in 10 quarters.
  • Cutler Group's Fulgent Genetics position peaked at $669K in Q1 2021.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.